HC Wainwright Weighs in on Longeveron Inc.’s Q1 2024 Earnings (NASDAQ:LGVN)

Longeveron Inc. (NASDAQ:LGVN) – HC Wainwright issued their Q1 2024 earnings estimates for Longeveron in a note issued to investors on Monday, April 29th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings per share of ($1.31) for the quarter. HC Wainwright currently has a “Buy” rating and a $12.00 target price on the stock. The consensus estimate for Longeveron’s current full-year earnings is ($10.20) per share. HC Wainwright also issued estimates for Longeveron’s Q2 2024 earnings at ($0.91) EPS, Q3 2024 earnings at ($0.81) EPS, Q4 2024 earnings at ($0.64) EPS, FY2024 earnings at ($3.34) EPS, Q1 2025 earnings at ($0.51) EPS, Q2 2025 earnings at ($0.46) EPS, Q3 2025 earnings at ($0.36) EPS, Q4 2025 earnings at ($0.37) EPS and FY2025 earnings at ($1.64) EPS.

Longeveron (NASDAQ:LGVN) last posted its quarterly earnings data on Tuesday, February 27th. The company reported ($2.50) EPS for the quarter, missing analysts’ consensus estimates of ($2.10) by ($0.40). The company had revenue of $0.06 million for the quarter, compared to analysts’ expectations of $0.21 million. Longeveron had a negative return on equity of 209.14% and a negative net margin of 3,020.17%.

Longeveron Trading Up 1.8 %

Longeveron stock opened at $1.74 on Wednesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.21. The stock has a market cap of $4.37 million, a PE ratio of -0.17 and a beta of 0.21. The stock has a 50-day moving average price of $3.55 and a 200 day moving average price of $10.73. Longeveron has a 52 week low of $1.60 and a 52 week high of $44.00.

Insider Buying and Selling at Longeveron

In other news, Director Rock Soffer bought 31,915 shares of the firm’s stock in a transaction dated Thursday, April 11th. The stock was acquired at an average price of $2.35 per share, for a total transaction of $75,000.25. Following the acquisition, the director now owns 208,534 shares of the company’s stock, valued at $490,054.90. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, insider Joshua Hare purchased 106,383 shares of the firm’s stock in a transaction on Wednesday, April 10th. The stock was purchased at an average price of $2.35 per share, for a total transaction of $250,000.05. Following the acquisition, the insider now directly owns 590,727 shares in the company, valued at $1,388,208.45. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rock Soffer purchased 31,915 shares of the firm’s stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $2.35 per share, with a total value of $75,000.25. Following the acquisition, the director now owns 208,534 shares in the company, valued at $490,054.90. The disclosure for this purchase can be found here. Insiders acquired 148,936 shares of company stock worth $350,000 in the last 90 days. 24.34% of the stock is owned by company insiders.

Hedge Funds Weigh In On Longeveron

An institutional investor recently bought a new position in Longeveron stock. Armistice Capital LLC acquired a new position in shares of Longeveron Inc. (NASDAQ:LGVN) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,836,000 shares of the company’s stock, valued at approximately $2,497,000. Armistice Capital LLC owned about 7.31% of Longeveron at the end of the most recent reporting period. 10.01% of the stock is owned by institutional investors and hedge funds.

About Longeveron

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors.